Acetylation pharmacogenetics. The slow acetylator phenotype is caused by decreased or absent arylamine N-acetyltransferase in human liver.

The biochemical basis underlying the genetic polymorphism of drug N-acetylation was investigated using a combination of in vivo and in vitro assays for arylamine N-acetyltransferase (NAT) activity and content in human liver. The acetylator phenotype of 26 surgical patients was determined using caffe...

Descrizione completa

Dettagli Bibliografici

Pubblicato in:	J Clin Invest
Autori principali:	Grant, D M, Mörike, K, Eichelbaum, M, Meyer, U A
Natura:	Artigo
Lingua:	Inglês
Pubblicazione:	American Society for Clinical Investigation 1990
Soggetti:	Research Article
Accesso online:	https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC296518/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/2312737/ https://ncbi.nlm.nih.govhttps://doi.org/10.1172/JCI114527
Tags:	Aggiungi Tag Nessun Tag, puoi essere il primo ad aggiungerne!!